Biotechnology Florida, USA-based oncology focused bio-pharmaceutical firm Xcovery says its China-based affiliate Betta Pharma (SHE: 300558), which is its majority shareholder, has received approval from the National Medical Products Administration (NMPA) for ensartinib in China for the first-line treatment of ALK-positive non-small cell lung cancer (NSCLC). 23 March 2022